Soulpower Acquisition
SOUL · NYSE
About SOUL
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Apr 2, 2025
- Sector
- N/A
- Industry
- N/A
- Website
- soulpowerhq.com
SOUL key statistics
- Market cap
- 357.19M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 64.66K
- Volume
- 686
- Open price
- $10.51
- High today
- $10.51
- Low today
- $10.51
- 52 Week high
- $10.83
- 52 Week low
- $10.11
Soulpower Acquisition (SOUL) at a glance
Soulpower Acquisition (SOUL) last traded at $10.51, with a market cap of 357.19M and a price-to-earnings ratio of 0.00.
Volume so far is 686 shares, below the average of 64.66K shares a day.
Over the past year Soulpower Acquisition has ranged from $10.11 to $10.83, and now sits 56% of the way up that range.
SOUL news
- Press releasePRNewswire
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Soulpower Acquisition Corporation (NYSE: SOUL)
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.